Establishment of a human acute myeloid leukemia cell line (Kasumi-1) with 8;21 chromosome translocation.

No abstract is available for this paper.

• Publication year

  1991

• Venue

  Blood

• Publication date

  1991-05-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1182/BLOOD.V77.9.2031.2031PMID 2018839
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• In vitro differentiation of leukemic cells to eosinophils in the presence of interleukin-5 in two cases of acute myeloid leukemia with the translocation (8;21)(q22;q22).

  1990cited by this paper
• The molecular control of cell division, differentiation commitment and maturation in haemopoietic cells

  1989cited by this paper
• Interleukin-6 enhances growth factor-dependent proliferation of the blast cells of acute myeloblastic leukemia.

  1988cited by this paper
• A myeloid-related sequence that localizes to human chromosome 8q21.1-22.

  1988cited by this paper
• Synergism between interleukin-6 and interleukin-3 in supporting proliferation of human hematopoietic stem cells: comparison with interleukin-1 alpha.

  1988cited by this paper
• Morphologic, immunologic and cytogenetic (MIC) working classification of the acute myeloid leukaemias

  1988cited by this paper
• Localization of the human c-mos gene by in situ hybridization in two cases of acute nonlymphocytic leukemia type M2.

  1987cited by this paper
• Synergism between recombinant growth factors, GM-CSF and G-CSF, acting on the blast cells of acute myeloblastic leukemia.

  1987cited by this paper
• Recombinant gibbon interleukin 3 supports formation of human multilineage colonies and blast cell colonies in culture: comparison with recombinant human granulocyte-macrophage colony-stimulating factor.

  1987influential reference
• Hu-ets-2 is translocated to chromosome 8 in the t(8;21) in acute myelogenous leukemia.

  1986cited by this paper
• Hu-ets-1 and Hu-ets-2 genes are transposed in acute leukemias with (4;11) and (8;21) translocations.

  1986cited by this paper
• Isolation and analysis of the 21q+ chromosome in the acute myelogenous leukemia 8;21 translocation: evidence that c-mos is not translocated.

  1985influential reference
• The role of the c-mos gene in the 8;21 translocation in human acute myeloblastic leukemia.

  1985cited by this paper
• A monoclonal antibody reactive with normal and leukemic human myeloid progenitor cells.

  1984cited by this paper
• Antigenic analysis of hematopoiesis. III. A hematopoietic progenitor cell surface antigen defined by a monoclonal antibody raised against KG-1a cells.

  1984cited by this paper
• 8;21 translocation in acute granulocytic leukaemia: cytological, cytochemical and clinical features

  1984cited by this paper
• Expression of MY7 antigen on myeloid precursor cells.

  1983cited by this paper
• Modulation of surface antigens of a human monocyte cell line, U937, during incubation with T lymphocyte-conditioned medium: detection of T4 antigen and its presence on normal blood monocytes.

  1983cited by this paper
• Cytologic characterization and significance of normal karyotypes in t(8;21) acute myeloblastic leukemia.

  1982cited by this paper
• In vivo and in vitro activity of neutrophil alkaline phosphatase in acute myelocytic leukemia with 8;21 translocation.

  1981cited by this paper
• Phorbol diester-induced macrophage differentiation of leukemic blasts from patients with human myelogenous leukemia.

  1980cited by this paper
• Differentiation of human leukemias in response to 12-0-tetradecanoylphorbol-13-acetate in vitro.

  1980cited by this paper
• Hematologic and cytologic characterization of 8/21 translocation acute granulocytic leukemia.

  1979cited by this paper
• C‐G translocation in acute myelocytic leukemia with low neutrophil alkaline phosphatase activity

  1976cited by this paper
• Detection of specific sequences among DNA fragments separated by gel electrophoresis.

  1975cited by this paper
• Chromosomes 21-22 and neutrophil alkaline phosphatase in leukaemia.

  1968cited by this paper

• A framework integrating multiscale in silico modeling and experimental data predicts CAR-NK cell cytotoxicity across target cell types

  2026cites this paper
• Single-cell atlas of AML reveals age-related gene regulatory networks in t(8;21) AML

  2025cites this paper
• A new STAT3-based potency assay for human G-CSF analog therapeutics.

  2025cites this paper
• Leukemic fusion genes repress viral gene expression and expel adenovirus from persistently infected human B lymphocytes but evidence of the virus lingers behind

  2025cites this paper
• A framework integrating multiscale in-silico modeling and experimental data predicts CD33CAR-NK cytotoxicity across target cell types

  2025cites this paper
• Leukemic stem cells activate lineage inappropriate signalling pathways to promote their growth

  2024cites this paper
• Insight into the Role of the miR-584 Family in Human Cancers

  2024cites this paper
• Targeting pediatric cancers via T-cell recognition of the monomorphic MHC class I-related protein MR1

  2024cites this paper
• A strategy to design protein-based antagonists against type I cytokine receptors

  2024cites this paper
• A novel AML1-ETO/FTO positive feedback loop promotes leukemogenesis and Ara-C resistance via stabilizing IGFBP2 in t(8;21) acute myeloid leukemia

  2024cites this paper
• Exogenous dihomo-γ-linolenic acid triggers ferroptosis via ACSL4-mediated lipid metabolic reprogramming in acute myeloid leukemia cells

  2024cites this paper
• The ncBAF Complex Regulates Transcription in AML Through H3K27ac Sensing by BRD9

  2023cites this paper
• Combination Therapies Targeting Apoptosis in Paediatric AML: Understanding the Molecular Mechanisms of AML Treatments Using Phosphoproteomics

  2023cites this paper
• Choosing the Right Cell Line for Acute Myeloid Leukemia (AML) Research

  2023influential citation
• Leukemic stem cells hijack lineage inappropriate signalling pathways to promote their growth

  2023cites this paper
• Neutrophil nucleus: shaping the past & the future.

  2023cites this paper
• The Impact of Some Natural Phenolic Compounds on α-Glucosidase and Sorbitol Dehydrogenase Enzymes, and Anti-leukemia Cancer Potential, Spin Density Distributions, and in silico Studies.

  2022cites this paper
• Nanoparticle-mediated targeting of the fusion gene RUNX1/ETO in t(8;21)-positive acute myeloid leukaemia

  2022cites this paper
• Rac GTPases in acute myeloid leukemia cells: Expression profile and biological effects of pharmacological inhibition.

  2022cites this paper
• Discrete single-cell microRNA analysis for phenotyping the heterogeneity of acute myeloid leukemia.

  2022cites this paper
• Tumor necrosis factor-related apoptosis-inducing ligand is a novel transcriptional target of runt-related transcription factor 1

  2021cites this paper
• Cytoplasmic DNA accumulation preferentially triggers cell death of myeloid leukemia cells by interacting with intracellular DNA sensing pathway

  2021cites this paper
• Studying Neutrophil Function in vitro: Cell Models and Environmental Factors

  2021cites this paper
• Sensitivity of Acute Myelocytic Leukemia Cells to the Dienone Compound VLX1570 Is Associated with Inhibition of the Ubiquitin-Proteasome System

  2021cites this paper
• The long noncoding RNA HOTAIRM1 controlled by AML1 enhances glucocorticoid resistance by activating RHOA/ROCK1 pathway through suppressing ARHGAP18

  2021cites this paper
• ETV6-NTRK3 is Associated With Trisomy 8 and Sensitive to TRK Inhibitor in Hematologic Malignancy: Case Report of a Refractory AML and Review of the Literature

  2021cites this paper
• In Vitro Comparison of the Effects of Imatinib and Ponatinib on Chronic Myeloid Leukemia Progenitor/Stem Cell Features

  2020cites this paper
• A compound combination screening approach with potential to identify new treatment options for paediatric acute myeloid leukaemia

  2020cites this paper
• ERK Activity in Immature Leukemic Cells Drives Clonal Selection during Induction Therapy for Acute Myeloid Leukemia

  2020cites this paper
• Modelling t(8;21) acute myeloid leukaemia ‐ What have we learned?

  2020cites this paper
• Kasumi leukemia cell lines: characterization of tumor genomes with ethnic origin and scales of genomic alterations

  2020cites this paper
• MicroRNA‐34a‐mediated death of acute myeloid leukemia stem cells through apoptosis induction and exosome shedding inhibition via histone deacetylase 2 targeting

  2020cites this paper
• Elucidation of Novel Therapeutic Targets for Acute Myeloid Leukemias with RUNX1-RUNX1T1 Fusion

  2019cites this paper
• Regulation of drug metabolizing enzymes in the leukaemic bone marrow microenvironment

  2019cites this paper
• Myeloid translocation gene CBFA2T3 directs a relapse gene program and determines patient-specific outcomes in AML.

  2019cites this paper
• Inhibition of N822K T>A mutation-induced constitutive c-KIT activation in AML cells triggers apoptotic and autophagic pathways leading to death

  2019cites this paper
• Compositional analysis gives insight into leukaemia cell lines expression profiles compared to those within patient sub‐groups

  2018influential citation
• Therapeutic potential of GSK-J4, a histone demethylase KDM6B/JMJD3 inhibitor, for acute myeloid leukemia

  2018cites this paper
• miR-34c-5p promotes eradication of acute myeloid leukemia stem cells by inducing senescence through selective RAB27B targeting to inhibit exosome shedding

  2018cites this paper
• C/EBPα overrides epigenetic reprogramming by oncogenic transcription factors in acute myeloid leukemia.

  2018cites this paper
• Targeted RNA-sequencing for the quantification of measurable residual disease in acute myeloid leukemia

  2018cites this paper
• Comprehensive genetic diagnosis of acute myeloid leukemia by next-generation sequencing

  2018cites this paper
• ZFP36L2, a novel AML1 target gene, induces AML cells apoptosis and inhibits cell proliferation.

  2018cites this paper
• ASXL1 c.1934dup;p.Gly646Trpfs*12—a true somatic alteration requiring a new approach

  2017cites this paper
• Plumbagin enhances TRAIL-induced apoptosis of human leukemic Kasumi‑1 cells through upregulation of TRAIL death receptor expression, activation of caspase-8 and inhibition of cFLIP.

  2017cites this paper
• Prognostic and biological significance of the proangiogenic factor EGFL7 in acute myeloid leukemia

  2017cites this paper
• Regulation of ITGA6 and ITGB4 integrin genes by RUNX1 and epigenetic mechanisms

  2017cites this paper
• Antitumor Activity of Entrectinib, a Pan-TRK, ROS1, and ALK Inhibitor, in ETV6-NTRK3–Positive Acute Myeloid Leukemia

  2017cites this paper
• Chemical constituents and antileukemic activity of Eugenia dysenterica

  2017cites this paper
• CD70/CD27 signaling promotes blast stemness and is a viable therapeutic target in acute myeloid leukemia

  2017influential citation
• Canthin-6-one induces cell death, cell cycle arrest and differentiation in human myeloid leukemia cells.

  2017cites this paper
• BH3 mimetic ABT‐737 induces apoptosis in CD34+ acute myeloid leukemia cells and shows synergistic effect with conventional chemotherapeutic drugs

  2017cites this paper
• Targeted Next-Generation Sequencing for Detecting MLL Gene Fusions in Leukemia

  2017cites this paper
• Promiscuous targeting of bromodomains by bromosporine identifies BET proteins as master regulators of primary transcription response in leukemia

  2016cites this paper
• The Leukemia Inhibitory Factor Receptor Gene Is a Direct Target of RUNX1

  2016influential citation
• The Hematopoietic Transcription Factors RUNX1 and ERG Prevent AML1-ETO Oncogene Overexpression and Onset of the Apoptosis Program in t(8;21) AMLs.

  2016cites this paper
• Repositioning of bromocriptine for treatment of acute myeloid leukemia

  2016cites this paper
• Targeting GLI1 Suppresses Cell Growth and Enhances Chemosensitivity in CD34+ Enriched Acute Myeloid Leukemia Progenitor Cells

  2016cites this paper
• Identification of common and distinct epigenetic re-programming properties of Core-Binding Factor (CBF) Fusion Proteins

  2016cites this paper
• Aryl Hydrocarbon Receptor Antagonist StemRegenin 1 Promotes the Expansion of Human Promyelocytic Leukemia Cell Line, NB4.

  2016cites this paper
• UBASH3B/Sts-1-CBL axis regulates myeloid proliferation in human preleukemia induced by AML1-ETO

  2016cites this paper
• GATA Factor-Dependent Positive-Feedback Circuit in Acute Myeloid Leukemia Cells.

  2016cites this paper
• Fucoidan enhances the therapeutic potential of arsenic trioxide and all-trans retinoic acid in acute promyelocytic leukemia, in vitro and in vivo

  2016cites this paper
• Charles Darwin University Fucoidan enhances the therapeutic potential of arsenic trioxide and all-trans retinoic acid in acute promyelocytic leukemia, in vitro and in vivo Atashrazm,

  2016cites this paper
• Restoration of MYC-repressed targets mediates the negative effects of GM-CSF on RUNX1-ETO leukemogenicity

  2016cites this paper
• Chaperonin TRiC/CCT Recognizes Fusion Oncoprotein AML1-ETO through Subunit-Specific Interactions.

  2016cites this paper
• The anti-cancer activity of the natural product, fucoidan, in haematological malignancies

  2016cites this paper
• Emetine induces chemosensitivity and reduces clonogenicity of acute myeloid leukemia cells

  2016cites this paper
• Identification of common and distinct epigenetic re-programming properties of Core-Binding Factor (CBF) Fusion Proteins

  2016cites this paper
• Global Cell Proteome Profiling, Phospho-signaling and Quantitative 
Proteomics for Identification of New Biomarkers in Acute Myeloid 
Leukemia Patients

  2015cites this paper
• Genome-wide co-occupancy of AML1-ETO and N-CoR defines the t(8;21) AML signature in leukemic cells

  2015cites this paper
• Integration of microarray analysis into the clinical diagnosis of hematological malignancies: How much can we improve cytogenetic testing?

  2015cites this paper
• Galectin-3 mediates bone marrow microenvironment-induced drug resistance in acute leukemia cells via Wnt/β-catenin signaling pathway

  2015cites this paper
• Generierung Plasmodium falciparum-spezifischer humaner Antikörperformate aus Epstein-Barr Virus-transformierten B Lymphozyten semi-immuner Individuen

  2015cites this paper
• Novel Peptide Suppresses Gene Expressions of C-MYC and CCND1 in Kasumi-1 Cell Lines

  2015cites this paper
• Identification of a Novel C-Terminal Truncated WT1 Isoform with Antagonistic Effects against Major WT1 Isoforms

  2015cites this paper
• Dystroglycan Depletion Impairs Actin-Dependent Functions of Differentiated Kasumi-1 Cells

  2015influential citation
• Chaperonin TRiC/CCT Modulates the Folding and Activity of Leukemogenic Fusion Oncoprotein AML1-ETO*

  2015cites this paper
• Comparison of plasmid DNA versus PCR amplified gene of insert DNA for nucleofection in Kasumi-1 cells

  2015cites this paper
• A sensitive WST-8-based bioassay for PEGylated granulocyte colony stimulating factor using the NFS-60 cell line

  2015cites this paper
• All-Trans Retinoic Acid Activity in Acute Myeloid Leukemia: Role of Cytochrome P450 Enzyme Expression by the Microenvironment

  2015cites this paper
• Ginsenoside Rh2 Mitigates Pediatric Leukemia Through Suppression of Bcl-2 in Leukemia Cells

  2015cites this paper
• An investigation into the role of receptor tyrosine kinases in childhood Acute Lymphoblastic Leukaemia

  2014cites this paper
• Isolation and Characterization of CD 34 + Blast-Derived Exosomes in Acute Myeloid Leukemia

  2014cites this paper
• Multicolor analysis of cell surface marker of human leukemia cell lines using flow cytometry.

  2014cites this paper
• Isolation and Characterization of CD34+ Blast-Derived Exosomes in Acute Myeloid Leukemia

  2014cites this paper
• Exploring the genome-wide relation between copy number status and microRNA expression.

  2014cites this paper
• Immune evasion by oncogenic proteins of acute myeloid leukemia.

  2014cites this paper
• XIAP inhibitors induce differentiation and impair clonogenic capacity of acute myeloid leukemia stem cells

  2014cites this paper
• Minimal residual disease monitoring in t(8;21) acute myeloid leukemia based on RUNX1‐RUNX1T1 fusion quantification on genomic DNA

  2014cites this paper
• Hypermethylation and down-regulation of DLEU2 in paediatric acute myeloid leukaemia independent of embedded tumour suppressor miR-15a/16-1

  2014cites this paper
• CD82 regulates STAT5/IL‐10 and supports survival of acute myelogenous leukemia cells

  2014cites this paper
• MYELOID NEOPLASIA Immune evasion by oncogenic proteins of acute myeloid leukemia

  2014cites this paper
• Geographic heterogeneity of the AML1-ETO fusion gene in Iranian patients with acute myeloid leukemia.

  2014cites this paper
• A novel three-dimensional stromal-based model for in vitro chemotherapy sensitivity testing of leukemia cells

  2014cites this paper
• The Transcriptional Co-Repressor Myeloid Translocation Gene 16 Inhibits Glycolysis and Stimulates Mitochondrial Respiration

  2013cites this paper
• Dasatinib inhibits proliferation and induces apoptosis in the KASUMI-1 cell line bearing the t(8;21)(q22;q22) and the N822K c-kit mutation.

  2013cites this paper
• Novel mTOR inhibitory activity of ciclopirox enhances parthenolide antileukemia activity.

  2013cites this paper
• Low Amount Expression of Ku 70 Protein Related to Radiation-induced Chromosome Instability and Radiosensitivity in Normal Lymphocytes, and Leukemia and Lymphoma Cell Lines

  2013cites this paper
• CD72 regulates the growth of KIT-mutated leukemia cell line Kasumi-1

  2013influential citation